| Model Number |
15980-1 |
| Medical Device Problem Code |
Contamination /Decontamination Problem (2895)
|
| Health Effect - Clinical Codes |
Eye Injury (1845); Eye Burn (2523)
|
| Date of Event |
02/26/2024
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
810 nm ophthalmic laser systems are intended to deliver thermal (laser) energy to deliver an insult (burn) to the ciliary body.Conjunctival burns are a known and predicted complication associated with the use of any 810nm ophthalmic laser system (console and delivery device) when used to deliver transscleral treatment.Conjunctival burns are typically superficial andtypically pose no long-term threat to the patient (i.E., no adverse effect on patient disease state, no requirement for additionalfuture care).Typically, these burns resolve within 24-48 hours post op without additional intervention.The result of these burns requires no post-operative management nor change to the post-operative medication regimen within the normal post-operative appointment schedule.The most likely cause of the reported adverse event is suspected to be contamination (e.G., blood, tissue or betadine) on the probe tip when the laser was activated.The g-probe delivery device ifu warns that contamination at the tip may cause ophthalmic burns: "contamination of the fiber optic tip by blood or tissue char may result in ocular surface burns.Excessive energy may cause equatorial burns.Heavy perilimbal conjunctival pigmentation may result in local absorption and burns;therefore, avoid areas of heavy perilimbal pigmentation".
|
| |
|
Event or Problem Description
|
|
A 55 year male patient with a known history of moderate primary open angle glaucoma experienced two conjunctival burns in the right eye during treatment with the cyclo g6 laser console and the g-probe delivery device.As reported by the complainant, " on strarting the treatment,patient observed to have conjunctival burns.Probe was inspected and observed to be smoking, even at 1600 mw.Probe discontinued.New probe connected.Treatment completed with new probe." a retrobulbar block anesthetic was applied during the procedure, no vasconstrictor, liquid coupling agent or betadine solution was used.There was no subconjunctival hemorrhage or bleeding present in the surgical field during treatment.It is unknown if the user observed any pigmented legions or dark areas in the surgical field.The patient is recovering well and did not require any further managment.
|
| |
|
Search Alerts/Recalls
|